Concepedia

Author

Jeffrey Tyner

Oregon Health & Science UniversityORCID

Also Known As

Agarwal, Anupriya, Graham, Douglas K., J TYNER, J W Tyner, J. Tyner, J. W. Tyner, Jacqueline Boultwood, Jeffrey W. Tyner, Jeffrey Tyner, Jeffrey W Tyner

2.1K

Publications

22.6K

Citations

69

H-Index

77

Concepts

All Affiliations

Oregon Health & Science UniversityHoward Hughes Medical InstituteUniversity of UtahOHSU Knight Cancer InstituteStanford University
JT

About

Jeffrey Tyner is an author at Oregon Health & Science University specializing in medicine, cell biology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

33

51

7.9K

2

Health Sciences

6

6

673

3

Engineering

3

3

238

4

Natural Sciences

1

1

21

5

Public Health

1

1

84

Jeffrey Tyner

×

160

Publications

17.2K

Citations

64

H-Index

YearCitations

Functional genomic landscape of acute myeloid leukaemia

Jeffrey Tyner, Cristina E. Tognon, Daniel Bottomly,

Nature

2018

1.4K

AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance

Thomas O’Hare, William C. Shakespeare, Xiaotian Zhu,

Cancer Cell

2009

1.2K

Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma

David Clark, Saravana M. Dhanasekaran, Francesca Petralia,

Cell

2019

745

CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability

Brian J. Lannutti, Sarah Meadows, Sarah E.M. Herman,

Blood

2010

712

Proteogenomic and metabolomic characterization of human glioblastoma

Liang-Bo Wang, Alla Karpova, Marina Gritsenko,

Cancer Cell

2021

643

Oncogenic<i>CSF3R</i>Mutations in Chronic Neutrophilic Leukemia and Atypical CML

Julia E. Maxson, Jason Gotlib, Daniel A. Pollyea,

New England Journal of Medicine

2013

562

Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease

Edy Y. Kim, John T. Battaile, Anand C. Patel,

Nature Medicine

2008

520

Proteogenomic Characterization of Endometrial Carcinoma

Yongchao Dou, Emily Kawaler, Daniel Cui Zhou,

Cell

2020

496

The TP53 Apoptotic Network Is a Primary Mediator of Resistance to BCL2 Inhibition in AML Cells

Tamilla Nechiporuk, Stephen E. Kurtz, Olga Nikolova,

Cancer Discovery

2019

358

Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma

Chen Huang, Lijun Chen, Sara R. Savage,

Cancer Cell

2021

356

Page 1